This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
Veteran Astronaut Reacts to Humanity's First Moon Mission Since Apollo
Former NASA astronaut Charles Camarda reacts to tonight's Artemis II launch, humanity's first crewed journey around the moon in over 50 years.
Candy, Culture, and Cravings: How Hershey Turns Trends into Bestsellers
Hershey's VP of Marketing Dan Mohnshine reveals the brand's newest products, the story behind Dirty Soda Twizzlers, and how an iconic brand stays relevant.
How AI Is Quietly Transforming the Way America's Biggest Restaurants Operate
Lavu CEO Saleem Khatri joins to explain how AI-powered POS systems are changing how major franchises like KFC take orders, cut costs, and serve customers faster
How BillionToOne's Unity Testing System Is Redefining Prenatal Genetic Screening
BillionToOne's Jen Hoskovec breaks down the Unity test, the latest in prenatal genetic screening, and what it means for those born with genetic conditions.
Ingram Micro CFO on Navigating Market Uncertainty and Where AI Is Actually Delivering Results
Mike Zilis, CFO of Ingram Micro, breaks down capital strategy, current market pressures, and how to tell meaningful AI impact from the hype.
Your Pocket-Sized Bodyguard Is Here: Meet Bond!
Bond CEO Doron Kempel on how his company is putting professional-grade personal security in the hands of everyday Americans.
